Keyphrases
Cost-effectiveness
100%
Point-of-care
100%
C-reactive Protein
100%
Antibiotic Prescribing
100%
Prescribing Decisions
100%
Protein Testing
100%
Lower Respiratory Tract Infection
42%
Acute Cough
42%
Quality-adjusted Life Years
28%
Symptom Severity
28%
Health Care Services
14%
Sweden
14%
Comorbidity
14%
Patient Characteristics
14%
Patient Outcomes
14%
Presentation Management
14%
Recovery Time
14%
Diagnostic Interventions
14%
EQ-5D
14%
Health-related Quality of Life
14%
Diagnostic Tool
14%
Life-years Gained
14%
Primary Care Setting
14%
Norway
14%
POC Diagnostics
14%
QALYs Gained
14%
Willingness-to-pay Threshold
14%
Self-reported Symptoms
14%
Antibiotic Use
14%
Cost Outcomes
14%
Inflammatory Biomarkers
14%
Hierarchical Regression
14%
Regression Data
14%
Medicine and Dentistry
Cost-Effectiveness Analysis
100%
C Reactive Protein
100%
Health Care Cost
85%
Coughing
42%
Quality Adjusted Life Year
42%
Lower Respiratory Tract Infection
42%
Diagnosis
28%
Primary Health Care
14%
Comorbidity
14%
Clinician
14%
Biological Marker
14%
Quality of Life
14%
Observational Study
14%
Health Service
14%
Patient Characteristics
14%
Nursing and Health Professions
Cost Effectiveness Analysis
100%
C Reactive Protein
100%
Coughing
42%
Quality Adjusted Life Year
42%
Lower Respiratory Tract Infection
42%
Diagnosis
28%
Primary Medical Care
14%
Inflammation
14%
Comorbidity
14%
Quality of Life
14%
Treatment Outcome
14%
Biological Marker
14%
Health Care
14%
Pharmacology, Toxicology and Pharmaceutical Science
C Reactive Protein
100%
Coughing
42%
Lower Respiratory Tract Infection
42%
Observational Study
14%
Biological Marker
14%
Inflammation
14%
Comorbidity
14%